H.C. Wainwright Investment Conference
PharmAbcine, a clinical-stage biotech company focusing on the development of next- generation antibody therapeutics, announced today that the Company will participate in H.C. Wainright 23rd Annual Global Investment Conference taking place virtually from September 13-15, 2021.
■ Visit the H.C Wainright website for more details on the event
■ To request webcasting link for the company’s presentation video, visit the link below
■ The presentation video can be accessed starting from 7:00 AM (Eastern Standard Time) on Monday, September 13, 2021 and will be available for 90 days.)